arrow
C

Chiara Alessandra Cella

irccs european institute of oncology (ieo)
H指数:17
被引数:1,067

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project

在IMAGene项目中开发并验证用于高危人群早期检测胰腺癌的流行病学风险评分

2026-05-200
PRE
Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center

晚期卵巢癌新辅助化疗期间静脉血栓栓塞的发生率及危险因素:一家转诊中心的回顾性分析

2026-04-030
PRE
Anti-EGFR rechallenge compared with standard of care for patients with ctDNA RAS/BRAF wild-type chemorefractory metastatic colorectal cancer: a systematic review and meta-analysis
2026-02-040
PRE
A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study

一项关于吉西他滨和 Nab-Paclitaxel 作为换用维持治疗 versus 改良 FOLFIRINOX 作为一线化疗在晚期胰腺癌患者中的随机 III 期临床试验:PANThEON 研究

2025-11-280
PRE
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial
2025-04-080
OAAI
An Italian multicenter phase II trial of metronomic temozolomide in unfit patients with advanced neuroendocrine neoplasms: Interim analysis of the MeTe study

一项关于米兰多中心II期试验中,在不符合条件的晚期神经内分泌肿瘤患者中应用节律性替莫唑胺的意大利研究:MeTe研究的期中分析

2024-09-010
PRE
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment
2024-06-130
OAAI
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

Pemigatinib用于先前治疗过的局部晚期或转移性胆管癌患者的FGFR2融合或重排: 法国pemi-bil和意大利pemi-real队列研究的联合分析

2024-03-015
OAAI